The term multiple system atrophy (MSA) was introduced by Graham and Oppenheimer to describe a neurologic condition previously described as Shy-Drager syndrome (SDS), olivopontocerebellar atrophy (OPCA), or striatonigral degeneration (SND), depending on the clinical predominance of autonomic failure, cerebellar signs, or parkinsonism. Although some authors suggest that MSA can be used interchangeably with the generic term multiple system degeneration, it is more appropriate in our opinion to reserve MSA for cases of SDS, SND, and sporadic OPCA and not to include inherited OPCA or other multiple system degenerative conditions, such as Huntingtons disease (HD) and PSP
Multiple system atrophy (MSA) is the most rapidly progressive neurodegenerative disorder among the v...
Background: The second consensus criteria for the diagnosis of multiple system atrophy (MSA) are wid...
Multiple system atrophy (MSA) is a sporadic and rapidly progressive neurodegenerative disorder chara...
Multiple system atrophy (MSA) is a degenera-tive disease of the central nervous system. Dejerine and...
Multiple system atrophy (MSA) is a sporadic, neu-rodegenerative disorder, characterized by several c...
Shy-Drager syndrome is a subtype of multiple system atrophy (MSA), one of the three idiopathic neuro...
Multiple system atrophy (MSA) is an adult-onset progressive neurodegenerative disorder that manifest...
atrophy (MSA) to denote a neurodegenerative disease characterized clinically by varying combinations...
Multiple system atrophy (MSA) is a rare neurodegenerative disorder without any effective treatment i...
We report the results of a consensus conference on the diagnosis of multiple system atrophy (MSA). W...
International audienceMultiple system atrophy (MSA) is a rare and fatal neurodegenerative disorder c...
Introduction: Multiple system atrophy (MSA) is a progressive degenerative disorder of the central an...
To access publisher's full text version of this article. Please click on the hyperlink in Additional...
Multiple system atrophy (MSA) is a fatal, adult-onset neurodegenerative disorder of uncertain etiolo...
Multiple system atrophy (MSA) is the most rapidly progressive neurodegenerative disorder among the v...
Background: The second consensus criteria for the diagnosis of multiple system atrophy (MSA) are wid...
Multiple system atrophy (MSA) is a sporadic and rapidly progressive neurodegenerative disorder chara...
Multiple system atrophy (MSA) is a degenera-tive disease of the central nervous system. Dejerine and...
Multiple system atrophy (MSA) is a sporadic, neu-rodegenerative disorder, characterized by several c...
Shy-Drager syndrome is a subtype of multiple system atrophy (MSA), one of the three idiopathic neuro...
Multiple system atrophy (MSA) is an adult-onset progressive neurodegenerative disorder that manifest...
atrophy (MSA) to denote a neurodegenerative disease characterized clinically by varying combinations...
Multiple system atrophy (MSA) is a rare neurodegenerative disorder without any effective treatment i...
We report the results of a consensus conference on the diagnosis of multiple system atrophy (MSA). W...
International audienceMultiple system atrophy (MSA) is a rare and fatal neurodegenerative disorder c...
Introduction: Multiple system atrophy (MSA) is a progressive degenerative disorder of the central an...
To access publisher's full text version of this article. Please click on the hyperlink in Additional...
Multiple system atrophy (MSA) is a fatal, adult-onset neurodegenerative disorder of uncertain etiolo...
Multiple system atrophy (MSA) is the most rapidly progressive neurodegenerative disorder among the v...
Background: The second consensus criteria for the diagnosis of multiple system atrophy (MSA) are wid...
Multiple system atrophy (MSA) is a sporadic and rapidly progressive neurodegenerative disorder chara...